Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 11, 2009, Pages 4575-4583

  Luotola, Kari ^a   Pääkkönen, Rauni ^b   Alanne, Mervi ^a,e   Lanki, Timo ^d   Moilanen, Leena ^f   Surakka, Ida ^a   Pietilä, Arto ^b   Kähönen, Mika ^g   Nieminen, Markku S ^a   Kesäniemi, Y Antero ^h   Peters, Annette ⁱ   Jula, Antti ^c   Perola, Markus ^a   Salomaa, Veikko ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Department of Chronic Disease Prevention ^*  (Finland)

^c Health and Functional Capacity   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e WIHURI RESEARCH INSTITUTE   (Finland)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h UNIVERSITY OF OULU   (Finland)

ⁱ INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ALLELE; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HAPLOTYPE; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70449125796     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0666     Document Type: Article

References (32)

1. Ross R 1999 Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126
2. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808 (Pubitemid 38063703)
3. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830 (Pubitemid 38063705)
4. Arend WP 2002 The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 13:323-340
5. Dinarello CA 2009 Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550
6. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulangé A, Capeau J, Caron M 2006 Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes. Diabetologia 49:2162-2173 (Pubitemid 44168485)
7. Jager J, Grémeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF 2007 Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148:241-251 (Pubitemid 46021456)
8. Peters A, Schneider A, Greven S, Bellander T, Forastiere F, Ibald-Mulli A, Illig T, Jacquemin B, Katsouyanni K, Koenig W, Lanki T, Pekkanen J, Pershagen G, Picciotto S, Ruckerl R, Rosario AS, Stefanadis C, Sunyer J; AIRGENE Study Group 2007 Air pollution and inflammatory response in myocardial infarction survivors: gene-environment interactions in a high-risk group. Inhal Toxicol 19(Suppl 1):161-175 (Pubitemid 47450700)
9. Aromaa A, Koskinen S 2004 Health and functional capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey. Publications of the National Public Health Institute B12/2004. Helsinki: National Public Health Institute
10. World Health Organization 1999 Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization
11. 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197 (Pubitemid 27274286)
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
13. National Heart, Lung, and Blood Institute, SeattleSNPs. Program for Genomic Applications. Seattle, WA: SeattleSNPs (pga.gs.washington.edu, accessed September 2005)
14. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D 2005 Efficiency and power in genetic association studies. Nat Genet 37:1217-1223 (Pubitemid 41568704)
15. Barrett JC, Fry B, Maller J, Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265 (Pubitemid 40202029)
16. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D 2002 The structure of haplotype blocks in the human genome. Science 296:2225-2229 (Pubitemid 34680308)
17. Stephens M, Donnelly P 2003 A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169 (Pubitemid 37414228)
18. Menashe I, Rosenberg PS, Chen BE 2008 PGA: Power calculator for case-control genetic association analyses. BMC Genet 9:36 (Pubitemid 351715983)
19. National Institutes of Health, Framingham SHARe (SNP Health Association Resource). Framingham Heart Study Genotype/Phenotype Data, NHLBI and Boston University. Bethesda, MD: NIH, Department of Health and Human Services (www.ncbi.nlm.nih.gov/sites/entrez?db=gap, accessed April 2008)
20. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PI, Abecasis GR, Almgren P, Andersen G, Ardlie K, Boström KB, Bergman RN, Bonnycastle LL, Borch-Johnsen K, Burtt NP, Chen H, Chines PS, Daly MJ, Deodhar P, Ding CJ, Doney AS, Duren WL, Elliott KS, Erdos MR, Frayling TM, Freathy RM, Gianniny L, Grallert H, Grarup N, Groves CJ, Guiducci C, Hansen T, Herder C, Hitman GA, Hughes TE, Isomaa B, Jackson AU, Jørgensen T, Kong A, Kubalanza K, Kuruvilla FG, Kuusisto J, Langenberg C, Lango H, Lauritzen T, Li Y, Lindgren CM, Lyssenko V, Marvelle AF, Meisinger C, Midthjell K, Mohlke KL, Morken MA, Morris AD, Narisu N, Nilsson P, Owen KR, Palmer CN, Payne F, Perry JR, Pettersen E, Platou C, Prokopenko I, Qi L, Qin L, Rayner NW, Rees M, Roix JJ, Sandbaek A, Shields B, Sjögren M, Steinthorsdottir V, Stringham HM, Swift AJ, Thorleifsson G, Thorsteinsdottir U, Timpson NJ, Tuomi T, Tuomilehto J, Walker M, Watanabe RM, Weedon MN, Willer CJ, Illig T, Hveem K, Hu FB, Laakso M, Stefansson K, Pedersen O, Wareham NJ, Barroso I, Hattersley AT, Collins FS, Groop L, McCarthy MI, Boehnke M, Altshuler D 2008 Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638-645 (Pubitemid 351601209)
21. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I, Lauretani F, Murray A, Gibbs JR, Paolisso G, Rafiq S, Simon-Sanchez J, Lango H, Scholz S, Weedon MN, Arepalli S, Rice N, Washecka N, Hurst A, Britton A, Henley W, van de Leemput J, Li R, Newman AB, Tranah G, Harris T, Panicker V, Dayan C, Bennett A, McCarthy MI, Ruokonen A, Jarvelin MR, Guralnik J, Bandinelli S, Frayling TM, Singleton A, Ferrucci L 2008 A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 4:e1000072 (Pubitemid 351811508)
22. Rafiq S, Melzer D, Weedon MN, Lango H, Saxena R, Scott LJ; DIAGRAM Consortium, Palmer CN, Morris AD, McCarthy MI, Ferrucci L, Hattersley AT, Zeggini E, Frayling TM 2008 Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Diabetologia 51:2205-2213
23. Rafiq S, Stevens K, Hurst AJ, Murray A, Henley W, Weedon MN, Bandinelli S, Corsi AM, Guralnik JM, Ferruci L, Melzer D, Frayling TM 2007 Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun 8:344-351 (Pubitemid 46888042)
24. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, Shepard JM, Williams SR, Risch N, Hinds D, Iwasaki N, Ogata M, Omori Y, Petzold C, Rietzch H, Schröder HE, Schulze J, Cox NJ, Menzel S, Boriraj VV, Chen X, Lim LR, Lindner T, Mereu LE, Wang YQ, Xiang K, Yamagata K, Yang Y, Bell GI 1996 A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13:161-166 (Pubitemid 26000435)
25. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI 2000 Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175 (Pubitemid 30764497)
26. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, Hanis CL, Hasstedt SJ 2002 Role of calpain-10 gene variants in familial type 2 diabetes in caucasians. J Clin Endocrinol Metab 87:650-654 (Pubitemid 34158232)
27. Elbein SC, Das SK, Hallman DM, Hanis CL, Hasstedt SJ 2009 Genome-wide linkage and admixture mapping of type 2 diabetes in African American families from the American Diabetes Association GENNID (genetics of NIDDM) study cohort. Diabetes 58:268-274
28. del Rey A, Monge-Arditi G, Besedovsky HO 1998 Central and peripheral mechanisms contribute to the hypoglycemia induced by interleukin-1. Ann NY Acad Sci 840:153-161 (Pubitemid 28302046)
29. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY 2002 Glucose-induced β-cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860 (Pubitemid 35050963)
30. + channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. Diabetes 53:1706-1713
31. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY 2007 Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517-1526 (Pubitemid 46588416)
32. Donath MY, Weder C, Whitmore J, Bauer RJ, Der K, Scannon PJ, C.A. Dinarello CA, Solinger AM 2008 XOMA 052, an anti-IL-1β antibody, in a double-blind, placebo-controlled, dose escalation study of the safety and pharmacokinetics in patients with type 2 diabetes mellitus: a new approach to therapy. Diabetologia 51(S1):S7